MSC Stem Cell Therapy

The basics

What are MSCs?

Mesenchymal stem cells (MSCs) are adult stem cells found in tissues throughout the body — most commonly sourced for clinical use from umbilical cord tissue, bone marrow, or adipose (fat) tissue. Unlike embryonic stem cells, MSCs are collected from consenting adult donors or ethically donated birth tissue, which removes the ethical questions that surround other cell types.

What makes MSCs interesting to researchers isn't primarily that they can become other cell types. It's that they are signaling cells. MSCs release growth factors, cytokines, and extracellular vesicles that influence the behavior of nearby cells — modulating inflammation, supporting tissue repair processes, and communicating with the immune system.

That signaling role — sometimes called the paracrine effect — is the mechanism behind most of the current clinical research interest.

How MSCs are used

Physicians administer MSCs in a few standard ways, chosen based on the condition being addressed:

• Intravenous (IV) administration — systemic delivery, typically used for autoimmune, organ, neurological, and wellness protocols.
• Image-guided injection — direct delivery into a joint, tendon, or specific site, common for orthopedic and sports-injury cases.
• Combination protocols — some physicians pair local injection with IV therapy, or with exosome therapy, depending on the case.

Which approach applies to you is a physician's determination made after reviewing your records — not something a website should tell you.

Conditions commonly studied

Research and clinical use span a broad range. The most commonly explored areas include:

• Osteoarthritis and degenerative joint conditions
• Tendon, ligament, and sports injuries
• Autoimmune conditions including RA, lupus, and MS
• Neurological conditions including stroke recovery, TBI, and neuropathy
• Chronic organ conditions affecting kidney, liver, and lung function
• Inflammatory and healthy-aging wellness protocols

The treatment process

A typical CPRT-coordinated MSC journey runs like this:

• Records review — your history, imaging, and labs are evaluated by the physician team before anything is scheduled.
• Protocol recommendation — cell type, dose, route, and number of sessions are proposed and explained to you.
• Pre-treatment labs — baseline bloodwork on the hospital campus prior to administration.
• Administration — IV infusion typically takes 30–90 minutes; guided injections are usually shorter. Both are outpatient procedures in a hospital setting.
• Observation — monitored rest following administration, with the medical team on hand.
• Follow-up — CPRT coordinates check-ins and shares your documentation with your home care team.

Potential benefits — honestly framed

Patients pursue MSC therapy hoping for reduced inflammation, improved function, better pain management, or support for their body's repair processes. Published research and clinical experience suggest these are reasonable things to investigate.

They are not things anyone can promise you. Responses vary substantially between individuals, some patients notice no change, and where responses do occur they typically develop over weeks to months rather than immediately. Any provider guaranteeing an outcome is telling you something they cannot know.

Safety considerations

MSC administration is generally well tolerated in clinical settings, with the most commonly reported effects being mild and transient — temporary fatigue, low-grade fever, or injection-site soreness. As with any medical procedure, risks exist and must be discussed with your physician.

Factors that matter for your safety:

• The setting. CPRT coordinates treatment at a hospital campus with operating rooms, an emergency department, and laboratory services — not a standalone office.
• Cell sourcing and handling. Ask about the source, processing, and quality controls. Good programs answer directly.
• Honest candidacy screening. Active malignancy, certain infections, and other conditions may make treatment inappropriate. A physician who never says no is a warning sign.
• Your existing care team. Regenerative therapy should complement your ongoing medical care, never replace it.